APA

Armuzzi A., Pugliese D., Danese S., Rizzo G., Felice C., Marzo M., Andrisani G., Fiorino G., Nardone O. M., De Vitis I., Papa A., Rapaccini G. L. & Guidi L. (20150330). Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis. : Inflammatory bowel diseases.

Chicago

Armuzzi Alessandro, Pugliese Daniela, Danese Silvio, Rizzo Gianluca, Felice Carla, Marzo Manuela, Andrisani Gianluca, Fiorino Gionata, Nardone Olga Maria, De Vitis Italo, Papa Alfredo, Rapaccini Gian Lodovico and Guidi Luisa. 20150330. Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis. : Inflammatory bowel diseases.

Harvard

Armuzzi A., Pugliese D., Danese S., Rizzo G., Felice C., Marzo M., Andrisani G., Fiorino G., Nardone O. M., De Vitis I., Papa A., Rapaccini G. L. and Guidi L. (20150330). Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis. : Inflammatory bowel diseases.

MLA

Armuzzi Alessandro, Pugliese Daniela, Danese Silvio, Rizzo Gianluca, Felice Carla, Marzo Manuela, Andrisani Gianluca, Fiorino Gionata, Nardone Olga Maria, De Vitis Italo, Papa Alfredo, Rapaccini Gian Lodovico and Guidi Luisa. Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis. : Inflammatory bowel diseases. 20150330.